Marc Blockman
Impact in
-
- Antibiotic Use and Resistance
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- COVID-19 Clinical Research Studies 4
-
- Atrial Fibrillation Management and Outcomes 6
- Blood Pressure and Hypertension Studies 4
- Co-authors
- Karen Cohen (27 shared papers)B. Willems (2 shared papers)Ushma Mehta (6 shared papers)Johannes P. Mouton (13 shared papers)Tamara Kredo (8 shared papers)Karen I. Barnes (1 shared paper)David N Dürrheim (1 shared paper)Gary Maartens (11 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)South African Medical Journal (21 papers)Drug Safety (2 papers)Nurse Education in Practice (2 papers)AIDS Research and Therapy (2 papers)
- Partner nations
- South AfricaUnited KingdomUganda
In The Last Decade
Marc Blockman
69 papers receiving 798 citations
Peers
Comparison fields: 5 of 97
- Applied Microbiology and Biotechnology 101
- Toxicology 140
- Geriatrics and Gerontology 70
- Pharmacology 78
- Infectious Diseases 109
Countries citing papers authored by Marc Blockman
This map shows the geographic impact of Marc Blockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Blockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Blockman more than expected).
Fields of papers citing papers by Marc Blockman
This network shows the impact of papers produced by Marc Blockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Blockman. The network helps show where Marc Blockman may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Blockman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 105 | |
| 2 | 2014 | 70 | |
| 3 | 2018 | 64 | |
| 4 | 2016 | 63 | |
| 5 | 2018 | 50 | |
| 6 | 2020 | 33 | |
| 7 | 2020 | 30 | |
| 8 | 2018 | 26 | |
| 9 | 2010 | 25 | |
| 10 | 2015 | 22 | |
| 11 | 2020 | 21 | |
| 12 | 2021 | 21 | |
| 13 | A survey of hypertensive practices at two community health centres in Cape Town. | 2007 | 21 |
| 14 | 2013 | 18 | |
| 15 | 2009 | 16 | |
| 16 | 2014 | 16 | |
| 17 | 2021 | 15 | |
| 18 | 2021 | 15 | |
| 19 | Warfarin resistance : cardiovascular prescriber | 2008 | 12 |
| 20 | 2008 | 11 |
About Marc Blockman
Marc Blockman is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health, Pharmacology and Toxicology, having authored 77 papers that have together received 834 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Atrial Fibrillation Management and Outcomes (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Poisoning and overdose treatments (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Blood Pressure and Hypertension Studies (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (101 citations), Toxicology (140 citations), Geriatrics and Gerontology (70 citations), Pharmacology (78 citations) and Infectious Diseases (109 citations). Marc Blockman has collaborated with scholars based in South Africa, United Kingdom and Uganda. Frequent co-authors include Karen Cohen, B. Willems, Ushma Mehta, Johannes P. Mouton, Tamara Kredo, Karen I. Barnes, David N Dürrheim, Gary Maartens, Andy Parrish and Annemie Stewart. Their work appears in journals such as British Journal of Clinical Pharmacology, South African Medical Journal, Drug Safety, Nurse Education in Practice and AIDS Research and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.